GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $8,546,000 | +300.1% | 39,400 | +113.0% | 0.04% | +322.2% |
| Q4 2020 | $2,136,000 | +26.8% | 18,500 | +6.9% | 0.01% | 0.0% |
| Q3 2020 | $1,685,000 | -3.3% | 17,300 | +21.8% | 0.01% | -18.2% |
| Q2 2020 | $1,742,000 | -9.7% | 14,200 | -35.6% | 0.01% | -26.7% |
| Q1 2020 | $1,930,000 | -50.7% | 22,045 | -41.1% | 0.02% | -44.4% |
| Q4 2019 | $3,911,000 | +77.6% | 37,400 | +95.4% | 0.03% | +50.0% |
| Q3 2019 | $2,202,000 | -69.1% | 19,139 | -53.7% | 0.02% | -71.0% |
| Q2 2019 | $7,120,000 | -7.4% | 41,300 | -9.4% | 0.06% | +3.3% |
| Q1 2019 | $7,687,000 | +144.4% | 45,600 | +41.2% | 0.06% | +160.9% |
| Q4 2018 | $3,145,000 | +18.2% | 32,286 | +109.6% | 0.02% | +64.3% |
| Q3 2018 | $2,660,000 | +114.9% | 15,400 | +73.6% | 0.01% | +100.0% |
| Q2 2018 | $1,238,000 | +121.5% | 8,870 | +79.0% | 0.01% | +133.3% |
| Q1 2018 | $559,000 | -31.2% | 4,955 | -20.1% | 0.00% | -25.0% |
| Q4 2017 | $813,000 | -18.5% | 6,200 | -37.1% | 0.00% | 0.0% |
| Q3 2017 | $998,000 | +55.9% | 9,857 | +54.1% | 0.00% | +33.3% |
| Q2 2017 | $640,000 | -21.0% | 6,396 | -4.5% | 0.00% | -50.0% |
| Q1 2017 | $810,000 | +10.4% | 6,700 | +1.7% | 0.01% | +20.0% |
| Q4 2016 | $734,000 | +27.7% | 6,585 | +53.1% | 0.01% | +25.0% |
| Q3 2016 | $575,000 | -79.2% | 4,300 | -85.8% | 0.00% | -77.8% |
| Q2 2016 | $2,762,000 | -6.5% | 30,200 | -26.3% | 0.02% | -30.8% |
| Q1 2016 | $2,953,000 | +585.2% | 40,987 | +561.1% | 0.03% | +550.0% |
| Q4 2015 | $431,000 | -32.8% | 6,200 | -12.0% | 0.00% | -33.3% |
| Q3 2015 | $641,000 | -36.7% | 7,045 | -14.5% | 0.01% | -40.0% |
| Q2 2015 | $1,013,000 | – | 8,242 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|